|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Sales | |
| Cost of sales | |
| Gross profit | |
| Operating costs: | |
| Selling, general, and administrative | |
| Research and development | |
| Gain on sale of property | |
| Goodwill impairment | |
| Operating (loss) profit | |
| Non-operating expense, net: | |
| Interest expense, net | |
| Loss from divestiture | |
| Other non-operating expenses, net | |
| (Loss) earnings before income taxes | |
| Income tax expense | |
| Net (loss) earnings | |
| Net (loss) earnings per share: | |
| Basic (in dollars per share) | |
| Diluted (in dollars per share) | |
| Average common stock and common equivalent shares outstanding: | |
| Basic (in shares) | |
| Diluted (in shares) |
Loading...
